dr. udit verma on regorafenib in patients with mcrc
Published 8 years ago • 1K plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
1:38
dr. udit verma on managing regorafenib side effects in crc
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
7:35
use of regorafenib in refractory mcrc
-
5:31
practical advice for using regorafenib
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
9:34
regorafenib in colorectal cancer
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
1:28
dr. o’connor on real-world results with regorafenib in mcrc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
3:48
clinical experience with regorafenib in hcc
-
6:33
patient selection for regorafenib in crc
-
11:24
managing toxicities associated with regorafenib
-
3:14
when you have decided to prescribe regorafenib
-
11:36
panitumumab, regorafenib, and ziv-aflibercept in metastatic colorectal cancer
-
4:14
the use of regorafenib in clinical practice
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
4:28
proactive side effect management with regorafenib